BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4895778)

  • 1. Mechanisms of Graves' disease and endocrine exophthalmos.
    Anderson DR
    Am J Ophthalmol; 1969 Jul; 68(1):46-57. PubMed ID: 4895778
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocrine exophthalmos.
    Havard CW
    Br Med J; 1972 Feb; 1(5796):360-3. PubMed ID: 4550413
    [No Abstract]   [Full Text] [Related]  

  • 3. Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).
    McKenzie JM
    Metabolism; 1972 Sep; 21(9):883-94. PubMed ID: 4115791
    [No Abstract]   [Full Text] [Related]  

  • 4. Endocrine exophthalmos.
    Wilkins RB; Sessions RB
    Int Ophthalmol Clin; 1970; 10(1):71-84. PubMed ID: 5537363
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
    Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
    Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
    [No Abstract]   [Full Text] [Related]  

  • 6. [New ideas on the regulation of thyroid function by LATS (long-acting thyroid stimulator) and their repercussion on human pathology].
    Strumia E
    Minerva Med; 1967 Nov; 58(90):3879-85. PubMed ID: 5630606
    [No Abstract]   [Full Text] [Related]  

  • 7. Endocrine exophthalmos: an immunologic aberration.
    Kaplan HJ
    Ophthalmic Semin; 1977; 2(2):203-46. PubMed ID: 327376
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-acting thyroid stimulator and exophthalmos.
    Burke G
    Ann Intern Med; 1969 May; 70(5):1045-6. PubMed ID: 4181434
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis of Graves' ophthalmopathy without hyperthyroidism: long-acting thyroid stimulator (LATS) determination as laboratory adjunct.
    Gharib H; Mayberry WE
    Mayo Clin Proc; 1970 Jun; 45(6):444-9. PubMed ID: 4193249
    [No Abstract]   [Full Text] [Related]  

  • 10. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
    McKenzie JM; McCullagh EP
    J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.
    Sawhney RC; Kannan V; Rastogi GK
    J Assoc Physicians India; 1975 Feb; 23(2):111-4. PubMed ID: 1242389
    [No Abstract]   [Full Text] [Related]  

  • 12. Ophthalmic Graves' disease. Diagnosis and pathogenesis.
    Hall R; Kirkham K; Doniach D; el-Kabir D
    Lancet; 1970 Feb; 1(7643):375-8. PubMed ID: 4189686
    [No Abstract]   [Full Text] [Related]  

  • 13. [Graves-Basedow type ophthalmopathy and primary hypothyroidism].
    Cathelineau G; Fribourg-Desi M
    Nouv Presse Med; 1974 Sep; 3(32):1995-8. PubMed ID: 4372586
    [No Abstract]   [Full Text] [Related]  

  • 14. Thyrotropin-releasing hormone (a test to diagnose Graves' ophthalmopathy).
    Hyman BN; Johnson PC
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1975; 79(3 Pt 2):OP524-8. PubMed ID: 50663
    [No Abstract]   [Full Text] [Related]  

  • 15. Thyroid physiology and functional tests.
    Zellmann HE
    Major Probl Clin Surg; 1974; 15(0):55-70. PubMed ID: 4138680
    [No Abstract]   [Full Text] [Related]  

  • 16. The long-acting thyroid stimulatory: is it of importance in Graves' disease.
    McKenzie JM; Zakarija M; D'Amour P; Joasoo A
    N Z Med J; 1975 Jan; 81(531):18-21. PubMed ID: 165442
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.
    Chopra IJ; Chopra U; Orgiazzi J
    J Clin Endocrinol Metab; 1973 Dec; 37(6):955-67. PubMed ID: 4201831
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperthyroidism and demonstration of circulating long-acting thyroid stimulator following hypophysectomy for chromophobe adenoma.
    Burke G
    J Clin Endocrinol Metab; 1967 Aug; 27(8):1161-6. PubMed ID: 4166582
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-acting thyroid stimulator in Graves' disease.
    Sellers EA; Awad AG; Schönbaum E
    Lancet; 1970 Aug; 2(7668):335-8. PubMed ID: 4194442
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of triiodothyronine on cervical lymphoid structures, thyroid activity, IgG and IgM immunoglobulin level and exophthalmos in Graves' disease.
    Mahaux JE; Chamla-Soumenkoff J; Delcourt R; Nagel N; Levin S
    Acta Endocrinol (Copenh); 1969 Jul; 61(3):400-6. PubMed ID: 4184992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.